EarningsNxt
CalendarInsightsFor AgentsAbout
EarningsNxt

Earnings briefings in plain English, before and after the bell. Free calendar, Pro briefs at $8/mo.

Get briefs in your inbox For agents

Popular tickers

AAPLMSFTGOOGLAMZNNVDAMETATSLAJPMVUNHJNJWMT

Product

  • Earnings Calendar
  • Pricing
  • For Agents

Resources

  • Insights
  • API Reference
  • FAQ
  • llms.txt

Company

  • About
  • Contact
  • X / Twitter
  • StockTwits
  • Instagram

© 2026 EarningsNxt. For informational purposes only. Not financial advice. AI-assisted content may contain errors.

Terms of ServicePrivacy PolicyDisclaimerDisclosureAccessibilityDo Not Sell My Info
  1. Home
  2. NBIX

Equity Profile

NBIX

Neurocrine Biosciences, Inc.

Health CareBiotechnology$14.4B market cap

Earnings scorecard

Last 76Q

EPS beat streak

13Q

EPS beat rate

70%

Avg EPS surprise

+24.27%

Avg 1-day reaction

+0.13%

Earnings history

77 quarters
Full history
QuarterReportedEst.ActualSurprise1-day
Q3-2026UpcomingOct 28, 2026————Preview
Q2-2026Jul 30, 2026$1.96$2.85+51.84%+2.61%Preview
Q1-2026May 5, 2026$1.71$1.94+51.21%+0.74%Preview
Q4-2025Feb 11, 2026$1.78$1.88+5.56%-0.15%Preview
Q3-2025Oct 28, 2025$1.58$2.17+37.25%-1.05%Preview
Q2-2025Jul 30, 2025ProPreview
Q1-2025May 5, 2025ProPreview
Q4-2024Feb 6, 2025ProPreview
Q3-2024Oct 30, 2024ProPreview
Q2-2024Aug 1, 2024ProPreview
Q1-2024May 1, 2024ProPreview
Q4-2023Feb 7, 2024ProPreview
Q3-2023Oct 31, 2023ProPreview
Q2-2023Aug 1, 2023ProPreview
Q1-2023May 3, 2023ProPreview
Q4-2022Feb 6, 2023ProPreview
Q3-2022Nov 1, 2022ProPreview
Q2-2022Aug 4, 2022ProPreview
Q1-2022May 4, 2022ProPreview
Q4-2021Feb 11, 2022ProPreview
Q3-2021Nov 1, 2021ProPreview
Q2-2021Aug 3, 2021ProPreview
Q1-2021May 5, 2021ProPreview
Q4-2020Feb 4, 2021ProPreview
Q3-2020Nov 9, 2020ProPreview
Q2-2020Aug 3, 2020ProPreview
Q1-2020May 6, 2020ProPreview
Q4-2019Feb 4, 2020ProPreview
Q3-2019Nov 4, 2019ProPreview
Q2-2019Jul 29, 2019ProPreview
Q1-2019Apr 29, 2019ProPreview
Q4-2018Feb 5, 2019ProPreview
Q3-2018Nov 5, 2018ProPreview
Q2-2018Jul 31, 2018ProPreview
Q1-2018Apr 30, 2018ProPreview
Q4-2017Feb 13, 2018ProPreview
Q3-2017Nov 1, 2017ProPreview
Q2-2017Aug 3, 2017ProPreview
Q1-2017May 9, 2017ProPreview
Q4-2016Feb 14, 2017ProPreview
Q3-2016Nov 2, 2016ProPreview
Q2-2016Aug 3, 2016ProPreview
Q1-2016May 5, 2016ProPreview
Q4-2015Feb 11, 2016ProPreview
Q3-2015Oct 29, 2015ProPreview
Q2-2015Jul 29, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 9, 2015ProPreview
Q3-2014Nov 3, 2014ProPreview
Q2-2014Aug 6, 2014ProPreview
Q1-2014Apr 30, 2014ProPreview
Q4-2013Feb 6, 2014ProPreview
Q3-2013Oct 29, 2013ProPreview
Q2-2013Jul 25, 2013ProPreview
Q1-2013May 2, 2013ProPreview
Q4-2012Feb 8, 2013ProPreview
Q3-2012Oct 31, 2012ProPreview
Q2-2012Jul 31, 2012ProPreview
Q1-2012May 2, 2012ProPreview
Q4-2011Feb 8, 2012ProPreview
Q3-2011Oct 31, 2011ProPreview
Q2-2011Jul 28, 2011ProPreview
Q1-2011May 3, 2011ProPreview
Q4-2010Feb 10, 2011ProPreview
Q3-2010Oct 28, 2010ProPreview
Q2-2010Jul 28, 2010ProPreview
Q1-2010Apr 28, 2010ProPreview
Q4-2009Feb 3, 2010ProPreview
Q3-2009Oct 28, 2009ProPreview
Q2-2009Jul 29, 2009ProPreview
Q1-2009May 5, 2009ProPreview
Q4-2008Feb 3, 2009ProPreview
Q3-2008Oct 28, 2008ProPreview
Q2-2008Jul 30, 2008ProPreview
Q1-2008Apr 30, 2008ProPreview
Q4-2007Feb 5, 2008ProPreview
Q3-2007Nov 1, 2007ProPreview

Next report

Q3-2026

Wed, Oct 28

After the close

Est. EPS

—

Est. Rev

—

Read the preview

About NBIX

Sector
Health Care
Industry
Biotechnology
Market cap
$14.4B

72 earlier quarters of EPS results and stock reactions are part of Pro.

No charge today · $8/mo after 7 days · Cancel anytime

Q2-2025Jul 30, 2025ProPreview
Q1-2025May 5, 2025ProPreview
Q4-2024Feb 6, 2025Pro
Preview
Q3-2024Oct 30, 2024ProPreview
Q2-2024Aug 1, 2024ProPreview
Q1-2024May 1, 2024ProPreview
Q4-2023Feb 7, 2024ProPreview
Q3-2023Oct 31, 2023ProPreview
Q2-2023Aug 1, 2023ProPreview
Q1-2023May 3, 2023ProPreview
Q4-2022Feb 6, 2023ProPreview
Q3-2022Nov 1, 2022ProPreview
Q2-2022Aug 4, 2022ProPreview
Q1-2022May 4, 2022ProPreview
Q4-2021Feb 11, 2022ProPreview
Q3-2021Nov 1, 2021ProPreview
Q2-2021Aug 3, 2021ProPreview
Q1-2021May 5, 2021ProPreview
Q4-2020Feb 4, 2021ProPreview
Q3-2020Nov 9, 2020ProPreview
Q2-2020Aug 3, 2020ProPreview
Q1-2020May 6, 2020ProPreview
Q4-2019Feb 4, 2020ProPreview
Q3-2019Nov 4, 2019ProPreview
Q2-2019Jul 29, 2019ProPreview
Q1-2019Apr 29, 2019ProPreview
Q4-2018Feb 5, 2019ProPreview
Q3-2018Nov 5, 2018ProPreview
Q2-2018Jul 31, 2018ProPreview
Q1-2018Apr 30, 2018ProPreview
Q4-2017Feb 13, 2018ProPreview
Q3-2017Nov 1, 2017ProPreview
Q2-2017Aug 3, 2017ProPreview
Q1-2017May 9, 2017ProPreview
Q4-2016Feb 14, 2017ProPreview
Q3-2016Nov 2, 2016ProPreview
Q2-2016Aug 3, 2016ProPreview
Q1-2016May 5, 2016ProPreview
Q4-2015Feb 11, 2016ProPreview
Q3-2015Oct 29, 2015ProPreview
Q2-2015Jul 29, 2015ProPreview
Q1-2015Apr 30, 2015ProPreview
Q4-2014Feb 9, 2015ProPreview
Q3-2014Nov 3, 2014ProPreview
Q2-2014Aug 6, 2014ProPreview
Q1-2014Apr 30, 2014ProPreview
Q4-2013Feb 6, 2014ProPreview
Q3-2013Oct 29, 2013ProPreview
Q2-2013Jul 25, 2013ProPreview
Q1-2013May 2, 2013ProPreview
Q4-2012Feb 8, 2013ProPreview
Q3-2012Oct 31, 2012ProPreview
Q2-2012Jul 31, 2012ProPreview
Q1-2012May 2, 2012ProPreview
Q4-2011Feb 8, 2012ProPreview
Q3-2011Oct 31, 2011ProPreview
Q2-2011Jul 28, 2011ProPreview
Q1-2011May 3, 2011ProPreview
Q4-2010Feb 10, 2011ProPreview
Q3-2010Oct 28, 2010ProPreview
Q2-2010Jul 28, 2010ProPreview
Q1-2010Apr 28, 2010ProPreview
Q4-2009Feb 3, 2010ProPreview
Q3-2009Oct 28, 2009ProPreview
Q2-2009Jul 29, 2009ProPreview
Q1-2009May 5, 2009ProPreview
Q4-2008Feb 3, 2009ProPreview
Q3-2008Oct 28, 2008ProPreview
Q2-2008Jul 30, 2008ProPreview
Q1-2008Apr 30, 2008ProPreview
Q4-2007Feb 5, 2008ProPreview
Q3-2007Nov 1, 2007ProPreview